Faculty:Peter H AddyDuration:6 Hours 17 MinutesFormat:Audio and VideoCopyright:Jul 15, is Archive: 2020 Description Would you be able to spot your clients’ recreational use of psychedelics?.
Archive: Faculty:Peter H AddyDuration:6 Hours 17 MinutesFormat:Audio and VideoCopyright:Jul 15, 2020 Description Would you be able to spot your clients’ recreational use of psychedelics?
mean is What does psychedelic use for them (and you) in therapy?.
What does psychedelic use mean for them (and you) in therapy?
your clients is Would any of benefit from a psychedelic experience?.
Would any of your clients benefit from a psychedelic experience?
you is How will know?.
How will you know?
you is How will navigate the ethical dilemmas that may arise in session?Many of us were taught nothing about psychedelics, or were given out-of-date information based on early Prohibition era stories and policies..
How will you navigate the ethical dilemmas that may arise in session?Many of us were taught nothing about psychedelics, or were given out-of-date information based on early Prohibition era stories and policies.
psychotherapy is Psychedelic-assisted is effective in the treatment of a variety of mental health conditions, and the FDA has both approved phase III clinical trials and expanded access..
Psychedelic-assisted psychotherapy is effective in the treatment of a variety of mental health conditions, and the FDA has both approved phase III clinical trials and expanded access.
gaps is But there are between clinician awareness of psychedelic use, how psychedelics are used in carefully designed clinical trials, and how your clients use them in the real world.Complete this online training to bridge those gaps and confidently address your clients’ questions and experiences..
But there are gaps between clinician awareness of psychedelic use, how psychedelics are used in carefully designed clinical trials, and how your clients use them in the real world.Complete this online training to bridge those gaps and confidently address your clients’ questions and experiences.
You’ll is acquire the skills you need to navigate common ethical dilemmas that may arise from talking with your clients about possibly illegal activity.By completing this course, you’ll discover why clients use psychedelic substances and how this may impact their treatment.In this workshop, you will learn:Types of psychedelic substances & their effectsHow & why psychedelics are usedHow to talk to your clients about psychedelic substancesUpdates on research of the effectiveness of psychedelicsPurchase today, and get need-to-know information on psychedelic substances, a better understanding of the research and navigate these changing times!.
You’ll acquire the skills you need to navigate common ethical dilemmas that may arise from talking with your clients about possibly illegal activity.By completing this course, you’ll discover why clients use psychedelic substances and how this may impact their treatment.In this workshop, you will learn:Types of psychedelic substances & their effectsHow & why psychedelics are usedHow to talk to your clients about psychedelic substancesUpdates on research of the effectiveness of psychedelicsPurchase today, and get need-to-know information on psychedelic substances, a better understanding of the research and navigate these changing times!
Handouts Manual - is Psychedelics, Hallucinogens and Entheogens (2.6 MB) 77 Pages Available after Purchase Outline Types of Psychedelic Substances: What You Need to KnowClassic Psychedelics: LSD, Psilocybin, Mescaline, DMTEmpathogens: MDMADissociatives: Ketamine, Dextromethorphan, Nitrous OxideComplex Psychedelics: Ayahuasca, IbogaineOther Atypical Psychedelics: Salvia Divinorum, CannabisHistory & Context of Psychedelic Use: The ResearchEpidemiology: Who uses, how, & how oftenPharmacology: How they work in the brainIndigenous Use: How they work in cultureSafetyAddiction to psychedelicsMDMA is not ecstasyPotency & purity of “street drugs”Ibogaine & cardiac toxicityContemporary ResearchPTSDAddictionEnd-of-life anxietyDepressionOCDSocial anxietyLegal Avenues for Experiencing Psychedelics: Paths Clients May TakeClinical Trials for MDMA & psilocybinCultural TourismSouth American ayahuasca tourismCentral American mushroom tourismContemporary TourismMushroom tourism in the Netherlands, JamaicaChurch for ayahuasca & peyoteLegal PsychedelicsKetamine & cannabis clinicsThe strange case of SalviaExercise: Discuss psychedelics with your clientEthical Considerations for Your ClientsSexual abuse in psychedelics communitiesOuting & societal pushbackIsolation when your client has no communityLimitations of the related researchEthical Considerations in the Therapy RoomAssessment strategies to determine high riskThe entropic brain theoryDiagnoses that may benefit from psychedelic experiencesHow to talk about future illegal activitySpiritual bypassing: Using psychedelics to avoid working on yourselfExercise: Navigate ethical challengesPsychotherapy Preparation & IntegrationNon-directive counselingGrounding techniquesThe holotropic mind modelExercise: Practice counseling techniques Faculty Peter H Addy, PhD, LPC, LMHC Related seminars and products: 2 Peter H Addy, PhD, LPC, LMHC, has studied psychedelic substances and states and consciousness for 15 years..
Handouts Manual - Psychedelics, Hallucinogens and Entheogens (2.6 MB) 77 Pages Available after Purchase Outline Types of Psychedelic Substances: What You Need to KnowClassic Psychedelics: LSD, Psilocybin, Mescaline, DMTEmpathogens: MDMADissociatives: Ketamine, Dextromethorphan, Nitrous OxideComplex Psychedelics: Ayahuasca, IbogaineOther Atypical Psychedelics: Salvia Divinorum, CannabisHistory & Context of Psychedelic Use: The ResearchEpidemiology: Who uses, how, & how oftenPharmacology: How they work in the brainIndigenous Use: How they work in cultureSafetyAddiction to psychedelicsMDMA is not ecstasyPotency & purity of “street drugs”Ibogaine & cardiac toxicityContemporary ResearchPTSDAddictionEnd-of-life anxietyDepressionOCDSocial anxietyLegal Avenues for Experiencing Psychedelics: Paths Clients May TakeClinical Trials for MDMA & psilocybinCultural TourismSouth American ayahuasca tourismCentral American mushroom tourismContemporary TourismMushroom tourism in the Netherlands, JamaicaChurch for ayahuasca & peyoteLegal PsychedelicsKetamine & cannabis clinicsThe strange case of SalviaExercise: Discuss psychedelics with your clientEthical Considerations for Your ClientsSexual abuse in psychedelics communitiesOuting & societal pushbackIsolation when your client has no communityLimitations of the related researchEthical Considerations in the Therapy RoomAssessment strategies to determine high riskThe entropic brain theoryDiagnoses that may benefit from psychedelic experiencesHow to talk about future illegal activitySpiritual bypassing: Using psychedelics to avoid working on yourselfExercise: Navigate ethical challengesPsychotherapy Preparation & IntegrationNon-directive counselingGrounding techniquesThe holotropic mind modelExercise: Practice counseling techniques Faculty Peter H Addy, PhD, LPC, LMHC Related seminars and products: 2 Peter H Addy, PhD, LPC, LMHC, has studied psychedelic substances and states and consciousness for 15 years.
He is earned a PhD in clinical psychology studying transcendence, wholeness, and transformation and conducted one of the earliest studies of the atypical psychedelic plant Salvia divinorum in humans..
He earned a PhD in clinical psychology studying transcendence, wholeness, and transformation and conducted one of the earliest studies of the atypical psychedelic plant Salvia divinorum in humans.
He is continued refining his research and clinical skills at Yale University where he studied Salvia and other atypical psychedelics and co-founded the Yale Psychedelic Science Group..
He continued refining his research and clinical skills at Yale University where he studied Salvia and other atypical psychedelics and co-founded the Yale Psychedelic Science Group.
He is has completed postdoctoral training in substance use disorder treatment, participated in non-directive harm reduction and integration training at Burning Man, and traveled to Mexico to learn about indigenous use of psychedelic plants among the Mazatec people..
He has completed postdoctoral training in substance use disorder treatment, participated in non-directive harm reduction and integration training at Burning Man, and traveled to Mexico to learn about indigenous use of psychedelic plants among the Mazatec people.
He is is currently a psychotherapist in private practice in Washington and Oregon.Dr..
He is currently a psychotherapist in private practice in Washington and Oregon.Dr.
Addy is has presented internationally on a variety of subjects related to spirituality and transpersonal states, psychedelic science, and research methodology..
Addy has presented internationally on a variety of subjects related to spirituality and transpersonal states, psychedelic science, and research methodology.
Participants is consistently regarded his talks as informative, accessible, and humorous..
Participants consistently regarded his talks as informative, accessible, and humorous.
He is has written numerous scientific articles, book chapters, and popular press articles on typical and atypical psychedelics, substance abuse, and spirituality.Speaker Disclosures:Financial: Peter Addy maintains a private practice..
He has written numerous scientific articles, book chapters, and popular press articles on typical and atypical psychedelics, substance abuse, and spirituality.Speaker Disclosures:Financial: Peter Addy maintains a private practice.
He is receives a speaking honorarium from PESI, Inc.Non-financial: Peter Addy has no relevant non-financial relationship to disclose..
He receives a speaking honorarium from PESI, Inc.Non-financial: Peter Addy has no relevant non-financial relationship to disclose.